Koers DermTech, Inc. Nasdaq
Aandelen
VGG2379F1247
Medische apparatuur, benodigdheden & distributie
Omzet 2024 * | 16,2 mln. 15,05 mln. | Omzet 2025 * | 17,4 mln. 16,16 mln. | Marktkapitalisatie | 3,76 mln. 3,49 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -74 mln. -68,74 mln. | Nettowinst (verlies) 2025 * | -74 mln. -68,74 mln. | EV/omzet 2024 * | 0,23 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,22 x |
K/w-verhouding 2024 * |
-0,05
x | K/w-verhouding 2025 * |
-0,05
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 97,38% |
Recentste transcriptie over DermTech, Inc.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Bret Christensen
CEO | Chief Executive Officer | 53 | 08-05-23 |
Kevin Sun
DFI | Director of Finance/CFO | 46 | 01-08-19 |
Steven Stone
CTO | Chief Tech/Sci/R&D Officer | - | 28-07-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Kirk Malloy
BRD | Director/Board Member | 57 | 18-07-22 |
Mark Capone
BRD | Director/Board Member | 61 | 18-07-22 |
Cynthia Collins
BRD | Director/Board Member | 65 | 03-09-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-11,78% | 11,24 mld. | |
-13,76% | 7,29 mld. | |
+29,50% | 5,57 mld. | |
-19,19% | 3,68 mld. | |
+7,62% | 2,58 mld. | |
-65,24% | 2,33 mld. | |
-10,48% | 2,23 mld. | |
+27,80% | 2,21 mld. | |
-19,12% | 1,57 mld. |